Hydrogen Hybrid Technologies, Inc.

OTC: HYHY · Healthcare · Medical - Pharmaceuticals

Canadian filerHQ Pickering, ONReports USD

#966 of 1,394 Healthcare companies by revenuetop-quartile growth

EA Score

——

FH —DQ —GM —SS 42

v0.1 · 5/100 weight · pillars only

↑ revenue growth (YoY), listing tenure · ↓ market scale, return on equity

Methodology →

Revenue TTM

$287.7k

Rev growth YoY (TTM)

+16.1%

Net income (FY)

-$3.2M

Employees

—

Market cap

$2.8k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$291.2k$291.2k2008

Net income-$3.2M-$3.2M2008

Operating income-$3.1M-$3.1M2008

Total assets$2.3M$2.3M2008

Liabilities$1.4M$1.4M2008

Equity$912.7k$912.7k2008

Revenue trend

FY2005 – FY2008 · USD

FY05

FY06

$120.8k

FY07

$291.2k

FY08

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Hydrogen Hybrid Technologies, Inc. booked $291.2k in FY2008 revenue, growing 141% year over year — faster than most Healthcare companies we track, at a -1085.2% net margin.

Peers · Healthcare

eFFECTOR Therapeutics, Inc.——Imagenetix, Inc.——YourWay Cannabis Brands Inc.——Corix Bioscience, Inc.——

Key facts

CEOJan van Eck

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersPickering, ON

ExchangeOTC: HYHY

Employees—

IPO date2006-07-20

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.